Digital Access to genomic surveillance: Open science and public heal... The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens.
Partner Content Partner Content Precision Medicine Market will surpass USD 96600 million by ... Precision Medicine Market will surpass $96bn by 2024
Events Partner Content Genomics and Molecular Medicine - Bioinformatics Congress Bioinformatics has revolutionized the growth in the scale and complexity of biological data of the healthcare industry.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.